Peptostreptococcus Anaerobius

A Gram-positive, obligate anaerobic bacterium within the Firmicutes phylum (family Peptostreptococcaceae) that has emerged as a consistently enriched organism in the colorectal cancer tumor microenvironment. While fusobacterium nucleatum receives the most attention as a CRC-associated bacterium, P. anaerobius operates through a distinct pro-tumorigenic mechanism involving TLR2/TLR4 signaling, NF-kB activation, and cholesterol biosynthesis pathway upregulation — making it a complementary driver of colorectal carcinogenesis rather than a redundant player.

Taxonomy

  • Peptostreptococcus anaerobius — the type species of the genus.
  • Family Peptostreptococcaceae, order Clostridiales, class Clostridia.
  • Distinguished from the related genus parvimonas (formerly Peptostreptococcus micros) and peptostreptococcus stomatis, which has its own CRC associations.

Metal Dependencies

Iron:

  • Iron-sulfur cluster proteins support anaerobic energy metabolism in P. anaerobius.
  • The tumor microenvironment provides abundant iron from hemorrhage, neovascularization, and macrophage-mediated iron recycling — conditions that likely favor P. anaerobius colonization.
  • Iron availability in colorectal tumors may partly explain the selective enrichment of iron-dependent anaerobes like P. anaerobius alongside fusobacterium nucleatum and bacteroides fragilis.

Key Enzymes and Virulence Factors

  • Surface protein interactions with TLR2 and TLR4: P. anaerobius activates innate immune receptors on colonic epithelial cells and macrophages, triggering NF-kB-dependent inflammatory signaling. Unlike bacterial toxins that directly damage cells, this mechanism hijacks the host inflammatory response to create a pro-tumorigenic microenvironment.
  • Cholesterol biosynthesis pathway activation: P. anaerobius colonization upregulates cholesterol biosynthesis in colonic epithelial cells, promoting cell proliferation. Cholesterol is a critical membrane component for rapidly dividing cancer cells.
  • Putrescine biosynthesis: Production of the polyamine putrescine contributes to cell proliferation signaling in the tumor microenvironment.
  • ROS generation: P. anaerobius promotes reactive oxygen species production in colonocytes, contributing to DNA damage and genomic instability.

Ecological Role

In the Healthy Gut

P. anaerobius is a low-abundance commensal in the oral cavity and gut. It is commonly isolated from mixed anaerobic infections (abscesses, peritonitis) but is not typically a dominant member of the healthy colonic microbiota.

In the Tumor Microenvironment

P. anaerobius is specifically enriched in tumor tissue compared to adjacent normal mucosa [1]. Its tumor tropism may be driven by:

  • Iron availability from tumor hemorrhage
  • Hypoxic conditions that favor obligate anaerobes
  • Nutrient-rich necrotic tissue providing amino acid substrates

Conditions Associated

Colorectal Cancer

P. anaerobius is enriched in the CRC tumor microenvironment [1] and is cataloged alongside streptococcus gallolyticus, enterotoxigenic bacteroides fragilis, pks+ escherichia coli, fusobacterium nucleatum, and enterococcus faecalis as one of six bacteria with well-characterized pro-tumorigenic mechanisms [2].

The mechanistic triad:

  1. Immune modulation — TLR2/TLR4 activation → NF-kB → pro-inflammatory cytokines → tumor-promoting inflammation
  2. Metabolic reprogramming — cholesterol biosynthesis upregulation → enhanced cell proliferation
  3. Genotoxicity — ROS production → DNA damage → genomic instability

Key Studies

  • [1] (cross-sectional) — Identified P. anaerobius enrichment in the CRC tumor microenvironment.
  • [2] (review) — Cataloged the specific pro-tumorigenic mechanisms of P. anaerobius alongside five other CRC-associated bacteria.

Cross-References

References (8)

  1. Zhiguang Gao, Bomin Guo, Renyuan Gao et al. (2015). Microbiota disbiosis is associated with colorectal cancer. Frontiers in Microbiology. doi:10.3389/fmicb.2015.00020
  2. Hanus M, Parada-Venegas D, Landskron G et al. (2021). Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Frontiers in Immunology. doi:10.3389/fimmu.2021.612826
  3. Marius Troeseid, Susanne Dam Nielsen, Ivan Vujkovic-Cvijin (2024). Gut microbiome and cardiometabolic comorbidities in people living with HIV. Microbiome. doi:10.1186/s40168-024-01815-y
  4. Youwen Qin, Xin Tong, Wei-Jian Mei et al. (2024). Consistent signatures in the human gut microbiome of old- and young-onset colorectal cancer. Nature Communications. doi:10.1038/s41467-024-47523-x
  5. Zangeneh Z, Abdi-Ali A, Khamooshian K et al. (2021). Bacterial Variation in the Oral Microbiota in Multiple Sclerosis Patients. PLoS ONE. doi:10.1371/journal.pone.0260384
  6. Saito K, Koido S, Odamaki T et al. (2019). Metagenomic Analyses of the Gut Microbiota Associated with Colorectal Adenoma. PLOS ONE. doi:10.1371/journal.pone.0212406
  7. Qian Yang, Yaping Wang, Xinyi Wei et al. (2020). Yang 2020 — Vaginal Microbiome Alterations in HPV16 Infection by Shotgun Metagenomics. Frontiers in Cellular and Infection Microbiology. doi:10.3389/fcimb.2020.00286
  8. Filipe T. Lira Neto, Marina C. Viana, Federica Cariati et al. (2024). Neto 2024 — Effect of Environmental Factors on Seminal Microbiome and Impact on Sperm Quality. Frontiers in Endocrinology. doi:10.3389/fendo.2024.1348186